December 4, 2017 1:53 pm
Less than four years since the groundbreaking study linking gut microbiota to obesity, the race to develop microbiome therapies is in full sprint.
November 13, 2017 10:59 am
Delving deeper into genome sequences has highlighted the stark difference between information and insight.
November 13, 2017 11:02 am
One of the most important tools for dealing with this the antibiotic resistant challenge is rapid molecular testing.
October 31, 2017 4:00 pm
Blood-sucking vampire or blood disorder? A new study from Boston’s Children’s Hospital has discovered a genetic mutations that triggers a disease linked to vampire folklore.
October 19, 2017 12:57 pm
Kite Pharma’s Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second gene therapy approved by the FDA and the first for certain types of non-Hodgkin lymphoma (NHL).